Iwata H - Search Results

1

Trastuzumab Deruxtecan versus Trastuzumab Emtansine for Breast Cancer.

Cortés J, Kim SB, Chung WP, Im SA, Park YH, Hegg R, Kim MH, Tseng LM, Petry V, Chung CF, Iwata H, Hamilton E, Curigliano G, Xu B, Huang CS, Kim JH, Chiu JWY, Pedrini JL, Lee C, Liu Y, Cathcart J, Bako E, Verma S, Hurvitz SA; DESTINY-Breast03 Trial Investigators. Cortés J, et al. Among authors: iwata h. N Engl J Med. 2022 Mar 24;386(12):1143-1154. doi: 10.1056/NEJMoa2115022. N Engl J Med. 2022. PMID: 35320644 Clinical Trial.

2

Clinical usefulness of oral combination chemotherapy of 5'-deoxy-5-fluorouridine (5'-DFUR) and cyclophosphamide for metastatic breast cancer.

Yamashita T, Yamashita H, Itoh Y, Karamatsu S, Itoh K, Hara Y, Ando Y, Sugiura H, Kuzushima T, Toyama T, Iwata H, Kobayashi S, Iwase H. Yamashita T, et al. Among authors: iwata h. Breast Cancer. 2006;13(4):334-9. doi: 10.2325/jbcs.13.334. Breast Cancer. 2006. PMID: 17146158 Free article. Clinical Trial.

3

Perspective of trastuzumab treatment.

Iwata H. Iwata H. Breast Cancer. 2007;14(2):150-5. doi: 10.2325/jbcs.955. Breast Cancer. 2007. PMID: 17485899 Free article. Review.

4

[Current situation and features of chemotherapy for breast neoplasms].

Yamashita T, Iwata H. Yamashita T, et al. Among authors: iwata h. Nihon Rinsho. 2007 Jun 28;65 Suppl 6:495-9. Nihon Rinsho. 2007. PMID: 17682200 Review. Japanese. No abstract available.

5

One-carbon metabolism-related gene polymorphisms and risk of breast cancer.

Suzuki T, Matsuo K, Hirose K, Hiraki A, Kawase T, Watanabe M, Yamashita T, Iwata H, Tajima K. Suzuki T, et al. Among authors: iwata h. Carcinogenesis. 2008 Feb;29(2):356-62. doi: 10.1093/carcin/bgm295. Epub 2008 Jan 3. Carcinogenesis. 2008. PMID: 18174236

6

A case of HER2-positive male breast cancer with lung metastases showing a good response to trastuzumab and paclitaxel treatment.

Hayashi H, Kimura M, Yoshimoto N, Tsuzuki M, Tsunoda N, Fujita T, Yamashita T, Iwata H. Hayashi H, et al. Among authors: iwata h. Breast Cancer. 2009;16(2):136-40. doi: 10.1007/s12282-008-0060-1. Epub 2008 Jun 12. Breast Cancer. 2009. PMID: 18548321

7

Trastuzumab and vinorelbine as first-line therapy for HER2-overexpressing metastatic breast cancer: multicenter phase II and pharmacokinetic study in Japan.

Tokudome N, Ito Y, Hatake K, Toi M, Sano M, Iwata H, Sato Y, Saeki T, Aogi K, Takashima S. Tokudome N, et al. Among authors: iwata h. Anticancer Drugs. 2008 Aug;19(7):753-9. doi: 10.1097/CAD.0b013e328302eb15. Anticancer Drugs. 2008. PMID: 18594220 Clinical Trial.

8

Effect of soybean on breast cancer according to receptor status: a case-control study in Japan.

Suzuki T, Matsuo K, Tsunoda N, Hirose K, Hiraki A, Kawase T, Yamashita T, Iwata H, Tanaka H, Tajima K. Suzuki T, et al. Among authors: iwata h. Int J Cancer. 2008 Oct 1;123(7):1674-80. doi: 10.1002/ijc.23644. Int J Cancer. 2008. PMID: 18623079

9

Neo(adjuvant) trastuzumab treatment: current perspectives.

Iwata H. Iwata H. Breast Cancer. 2009;16(4):288-94. doi: 10.1007/s12282-009-0131-y. Epub 2009 Jul 17. Breast Cancer. 2009. PMID: 19609648 Review.

10

Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer.

Nakamura S, Yagata H, Ohno S, Yamaguchi H, Iwata H, Tsunoda N, Ito Y, Tokudome N, Toi M, Kuroi K, Suzuki E. Nakamura S, et al. Among authors: iwata h. Breast Cancer. 2010 Jul;17(3):199-204. doi: 10.1007/s12282-009-0139-3. Epub 2009 Aug 1. Breast Cancer. 2010. PMID: 19649686

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,054 results

Search Page

Filters